InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Halstead Michael, Vice-Président Exécutif. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. Cumulatively, 6 filings have been published. The latest transaction was disclosed on 21 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
7,906 shares
Common Stock
SEC:0001209191-22-013356:0·
11,139 shares
Common Stock
SEC:0001209191-22-012392:0·
19,639 shares
Common Stock
SEC:0001209191-22-002989·
19,639 shares
Common Stock
SEC:0001209191-22-002989:0·
€307,24825,000 shares@ €12.2899100.0% of flow
Common Stock
SEC:0001209191-21-071176·
€307,24825,000 shares@ €12.289950.0% of flow
Common Stock
SEC:0001209191-21-071176:0·
6 of 6 declarations
About Halstead Michael
Michael Halstead is Executive Vice President and General Counsel at Intra-Cellular Therapies, Inc. He is responsible for the company's legal affairs and compliance. His role is essential in navigating the complex regulatory landscape of the biopharmaceutical sector.
